Related to Promega Plans 260,000-Square-Foot Facility for Molecular Bio Products

• Biovest and Ordway Research Institute to Evaluate Firm's Technology for Producing Virus-Fighting Products
  
• CellMed to Leverage Scarab Genomics’ Clean Genome E. coli Technology
  
• OncoMed and Bayer HealthCare Sign Manufacturing Deal for Partnered Wnt Inhibitor
  
• Roslin Cells and Sistemic to Develop miRNA-Based Tools for Monitoring Stem Cell Integrity
  
• Miltenyi Biotec and TeutoCell Partner to Develop Cell Culture Media
  
• Northwest Biotherapeutics Signs on Fraunhofer IZI for Brain Cancer Vaccine Development
  
• Goodwin Biotechnology and Rafagen Ink Deal for Biomanufacturing and Cell-Line Development
  
• Unigene to Produce Clinical Material for Cara’s Phase I-Stage Peptide Drug
  
• PeptLab to Aid Biotage in Development of Technologies for Peptides
  
• Fujifilm Diosynth Biotechnologies Adds 1,000 L Single Use Bioreactor to NC Site
  
• APP Pharma to Plug $38M into Expanding NY Manufacturing Site
  
• United Therapeutics Signs $7M Up-Front Licensing Deal for Pluristem’s Placental Cell Platform
  
• Watson Invests $44M to Triple Capacity for Transdermal Patch and Topical Gel Manufacture
  
• Angel Biotech to Conduct Development and Manufacturing for ReNeuron’s Stem Cell Program
  
• Shimadzu UK Opens Evaluation Laboratory to Bolster Use of Customized Application Solutions
  
• Transgene and Vivalis to Evaluate MVA Vaccine Production in EB66 Duck Stem Cell Line
  
• Scil Technology Establishes Protein Formulation and Manufacturing Services Unit
  
• Cevec Raises $8.5M to Commercialize Human Cell-Expression Platform for Proteins and Vaccines
  
• Sanofi Pasteur to Evaluate Leukocare’s Stabilization Technology for Vaccines
  
• Genesis Signs On Lonza as Production Partner for Cancer Cell Therapy